Management team
Headquarters
CAMPUS MIGUEL DE UNAMUNO,
Salamanca
(Salamanca)
Spain,
923 29 47 20
http://www.cicancer.org/
INSTITUTO DE BIOLOGIA MOLECULAR Y CELULAR DEL CANCER DE SALAMANCA
A total of 21 Research groups belong to this institute
Pagination
A total of 61 Ongoing projects belong to this institute
IMMUNE CONTEXTURE AND TUMOR EVOLUTION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | |
CONTEXTO INMUNOLOGICO Y EVOLUCION TUMORAL EN LA LEUCEMIA LINFOBLASTICA DE CELULAS B | |
DISSECTING THE PATHOBIOLOGICAL AND THERAPEUTIC ROLE OF A NEW ONCOGENIC DRIVER ON T CELL LYMPHOMAGENESIS | |
DISECCION DEL PAPEL PATOBIOLOGICO Y TERAPEUTICO DE UN NUEVO DRIVER ONCOGENICO EN LINFOMAS DE CELULAS T | |
POTENTIAL THERAPEUTIC LIABILITIES CAUSED BY THE IMPACT OF ONCOGENIC DRIVERS ON THE MICROENVIRONMENT OF LUNG TUMOURS | |
IDENTIFICACION DE NUEVAS OPORTUNIDADES TERAPEUTICAS CAUSADAS POR MUTACIONES DE EGFR Y KRAS DURANTE LA FORMACION DEL MICROAMBIENTE DE TUMORES DE PULMON | |
BREAST CANCER PREVENTION BY ENHANCING POSTLACTATIONAL INVOLUTION WITH CABERGOLINE | |
CARACTERIZACION DE LA FUNCION Y POTENCIAL TERAPEUTICO DE LOS COMPLEJOS DEL ONCOGEN KRAS EN MEMBRANA | |
Mecanismos moleculares de resistencia a la inhibición de KRAS en un modelo de cáncer de pulmón. | |
Targeting RAS-PI3K signalling to re-educate the stroma of RAS mutant lung cancers. |
Pagination
There are no investigators related to this institute
A total of 20 Knowledge transference belong to this institute
Pagination
A total of 10 services belong to this institute
Location
CAMPUS MIGUEL DE UNAMUNO
Salamanca Salamanca
Spain